Lunai Bioworks
LNAI
15 hedge funds and large institutions have $518K invested in Lunai Bioworks in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 16 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
29% more capital invested
Capital invested by funds: $403K → $518K (+$115K)
2.99% more ownership
Funds ownership: 0.51% → 3.5% (+3%)
44% less funds holding
Funds holding: 27 → 15 (-12)
75% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 16
87% less call options, than puts
Call options by funds: $4K | Put options by funds: $31K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$146K |
| 2 |
Jane Street
New York
|
+$65.1K |
| 3 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$11.1K |
| 4 |
VF
Virtu Financial
New York
|
+$9.53K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
-$41.7K |
| 2 |
Citigroup
New York
|
-$40.8K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$21.4K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$15.2K |
| 5 |
State Street
Boston,
Massachusetts
|
-$14.6K |
LNAI Hedge Fund Activity: Q2 2026 in Review
15 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q2 2026, worth a combined $518K — up 29% from $403K a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of LNAI and 4 opened new positions — a net loss of 12 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was Ground Swell Capital, opening a new position worth an estimated $146K. The largest seller was Nine Masts Capital, exiting entirely with an estimated $41.7K sold.
- 15 institutional investors held Lunai Bioworks (LNAI) as of Q2 2026, down from 27 in Q1 2026.
- Funds reported $518K of Lunai Bioworks stock for Q2 2026, up 29% quarter-over-quarter.
- 4 funds opened new Lunai Bioworks positions in Q2 2026 and 16 closed out, a net change of -12 holders.
- The largest Lunai Bioworks buyer in Q2 2026 was Ground Swell Capital, an estimated $146K added.
- The largest Lunai Bioworks seller in Q2 2026 was Nine Masts Capital, an estimated $41.7K sold.
Based on aggregated 13F filings for Q2 2026.